| Market Cap | ₹1,630Cr |
| ROE | 13.86% |
| P/E Ratio(TTM) | 50.17 |
| EPS(TTM) | 6.24 |
| P/B Ratio | 7.72 |
| Dividend Yield | 0.00% |
| Industry P/E | 65.02 |
| Book Value | 40.56 |
| Debt to Equity | 0.51 |
| Face Value | 2 |
| Parent Organisation | Suraksha Diagnostic |
| NSE Symbol | SURAKSHA |
| FUND NAME | AUM(%) |
|---|---|
| Nippon India Pharma Fund Direct Growth | 1.43% |
| JM Value Fund Direct Plan Growth | 0.72% |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 47.53 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 68.87 | ||
| Metropolis Healthcare | NA (0.00%) | 63.84 | ||
| Thyrocare Technologies | NA (0.00%) | 58.09 |